Sensorion

Pre-IPO issuer

ipo filed CONFIDENTIAL-S1

Sensorion IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: CONFIDENTIAL-S1 on 2026-09-16.

Filing Timeline

Synthetic IPOGrid ID

CONFIDENTIAL-S1 filed

Confidential registration lead

Sensorion announced on September 16, 2026 that it confidentially submitted a draft Form F-1 to the SEC as a preliminary step in evaluating a potential U.S. IPO of ordinary shares, including ADSs. The ADSs would be listed on an unspecified U.S. national exchange, subject to market and other conditions. No U.S. ticker, offer size, price or timing was disclosed.

Ordinary shares, including in the form of American Depositary Shares · Flags adr, foreign_private_issuer

French biotechnology issuer Sensorion confirmed a confidential Form F-1 submission on September 16 to evaluate a potential U.S. IPO, potentially using ADSs. This is an early-stage filing signal without disclosed cover terms, syndicate, exchange, ticker or timetable.

2026-09-16 · CONFIDENTIAL-42D90D2B93BA2FB6EDEC

Comparable Deals

Not enough completed IPOs with similar characteristics to show comparables yet.

Recent News

Sensorion Announces Confidential Submission of Draft Registration Statement to the SEC for Potential U.S. Initial Public Offering

Sensorion via Business Wire · 2026-09-16T05:30:00.000Z

Sensorion annonce le dépôt confidentiel du projet de document d’enregistrement auprès de la SEC en vue d’une potentielle introduction en bourse aux Etats-Unis

Sensorion / Webdisclosure · 2026-09-16T05:30:00.000Z